CHA Vaccine Research Institute (KOSDAQ: 261780)
South Korea
· Delayed Price · Currency is KRW
3,735.00
+35.00 (0.95%)
Nov 15, 2024, 9:00 AM KST
CHA Vaccine Research Institute Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 99,176 | 151,036 | 131,749 | 293,364 | - | - | |
Market Cap Growth | -24.16% | 14.64% | -55.09% | - | - | - | |
Enterprise Value | 70,650 | 123,500 | 97,133 | 290,192 | - | - | |
Last Close Price | 3710.00 | 5650.00 | 4985.00 | 11100.00 | - | - | |
PS Ratio | 267.45 | 513.51 | 734.04 | 586.73 | - | - | |
PB Ratio | 3.04 | 4.26 | 3.95 | 7.41 | - | - | |
P/TBV Ratio | 3.41 | 4.27 | 3.95 | 7.41 | - | - | |
EV/Sales Ratio | 190.61 | 419.89 | 541.18 | 580.38 | - | - | |
Debt / Equity Ratio | 0.29 | 0.12 | 0.71 | 0.53 | 11.98 | -0.59 | |
Asset Turnover | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | - | |
Quick Ratio | 48.34 | 48.57 | 2.18 | 2.50 | 5.20 | 0.59 | |
Current Ratio | 60.10 | 52.44 | 2.20 | 2.50 | 5.21 | 0.59 | |
Return on Equity (ROE) | -13.49% | -5.09% | -18.40% | -89.44% | - | - | |
Return on Assets (ROA) | -8.16% | -7.56% | -6.40% | -8.35% | -14.99% | - | |
Return on Capital (ROIC) | -9.10% | -8.29% | -6.88% | -9.40% | -31.48% | - | |
Earnings Yield | -4.30% | -1.16% | -5.10% | -6.28% | - | - | |
FCF Yield | -6.41% | -3.69% | -4.28% | -1.85% | - | - | |
Buyback Yield / Dilution | -0.39% | -0.69% | -13.39% | -30.03% | - | - | |
Total Shareholder Return | -0.39% | -0.69% | -13.39% | -30.03% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.